20 Myths About ADHD Medication Pregnancy: Dispelled
ADHD Medication During Pregnancy and Breastfeeding
Women with ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There isn't much information on how long-term exposure to these drugs can affect the foetus.
A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are required.
Risk/Benefit Analysis
Women who are pregnant and take ADHD medication must evaluate the benefits of using it versus the risks to the fetus. Doctors don't have enough data to make unambiguous recommendations however they can provide information about risks and benefits to help pregnant women make informed choices.
A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy were not at greater risk of fetal malformations or structural birth defects. Researchers used a large sample-based case control study to examine the prevalence of structural defects that were major in infants who were born to mothers who used stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to confirm that the classification was accurate and to reduce any bias.
The research conducted by the researchers had some limitations. The researchers were unable in the beginning, to separate the effects triggered by the medication from the disorder. This limitation makes it difficult for researchers to determine if the small differences observed between the groups that were exposed to the use of medication, or if they were caused by the presence of comorbidities. Additionally, the researchers did not look at the long-term outcomes of offspring.
The study did show that babies whose mothers had taken ADHD medication during pregnancy were at a more risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or taken off their medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication that was used during pregnancy.
Women who took stimulant ADHD medications used to treat adhd during pregnancy also had a higher risk of having a caesarean section or a baby that scored low on the Apgar scale (less than 7). These risks did not appear to be affected by the type of medication that was used during pregnancy.
The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy may be offset by the higher benefit to both the mother and child from continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, where possible, assist them in developing strategies to improve their coping abilities that can lessen the effects of her disorder on her daily life and relationships.
Medication Interactions
Many doctors are faced with the decision of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. Often, these decisions are made in the absence of any evidence that is clear and definitive regardless, so doctors have to weigh their experience about their experiences, the experiences of other doctors, and what medications are prescribed for adhd research says on the topic, along with their own best adhd medication for adults with anxiety judgment for each individual patient.
The issue of possible risks to infants is extremely difficult. Many of the studies on this topic are based on observational data rather than controlled research and their findings are often contradictory. Additionally, the majority of studies limit their analysis to live births, which can underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study presented in the journal club addresses these issues by analyzing both information on deceased and live births.
Conclusion: While some studies have shown an association between ADHD medications and certain birth defects however, other studies haven't established a link. Most studies show a neutral, or even slightly negative, effect. Therefore, a careful risk/benefit assessment must be done in each instance.
For women suffering from ADHD who suffer from ADHD, the decision to stop taking medication can be difficult, if not impossible. In fact, in an article published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation, and family conflict for patients with ADHD. The loss of medication can affect the ability to safely drive and complete work-related tasks, which are crucial aspects of normal life for people with ADHD.
She suggests that women who are unsure whether to continue taking the medication given for adhd (by Livebookmark) or stop due to pregnancy, educate their family members, colleagues, and their friends about the condition, its effects on daily functioning, and the benefits of keeping the current treatment plan. In addition, educating them can help the woman feel supported in her struggle with her decision. It is also worth noting that certain medications can be absorbed through the placenta therefore, if a patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the drug can be passed on to the baby.
Risk of Birth Defects
As the use of adhd medication names list medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about what impact the medications could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. Researchers used two massive datasets to analyze over 4.3 million pregnant women and determine whether stimulant medications increased the risk of birth defects. Researchers found that while the overall risk is low, the first trimester ADHD medication use was associated with slightly higher rates of certain heart defects, like ventriculoseptal defects.
The researchers of the study found no connection between early medication use and congenital abnormalities like facial clefting, or club foot. The results are in line with previous studies that have shown an increase, but not significant, in the risk of cardiac malformations in women who started taking ADHD medications prior to the time of the time of pregnancy. This risk increased during the latter part of pregnancy, when a lot of women are forced to stop taking their ADHD medication.
Women who used ADHD medication in the first trimester of pregnancy were also more likely to experience caesarean sections, a low Apgar score after delivery and a baby that required breathing assistance at birth. However the authors of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have any other medical conditions that could have contributed to these findings.
Researchers hope their research will help doctors when they encounter pregnant women. They suggest that although a discussion of the risks and benefits is crucial but the decision to stop or continue treatment must be based on each woman's needs and the severity of her ADHD symptoms.
The authors warn that, even though stopping the medication is a possibility to consider, it is not advised due to the high rate depression and mental health issues among women who are pregnant or have recently given birth. Further, the research suggests that women who decide to stop taking their medications are more likely to have difficulties getting used to life without them after the baby's arrival.
Nursing
The responsibilities of being a new mother can be overwhelming. Women with ADHD can face severe challenges when they must deal with their symptoms, go to doctor appointments, prepare for the birth of a baby and adjust to a new routine. Many women decide to continue taking their ADHD medication during pregnancy.
The majority of stimulant medications pass through breast milk in very small amounts, therefore the risk to the breastfeeding infant is minimal. However, the amount of exposure to medication by the newborn can vary depending on dosage, frequency it is administered, and the time of day it is administered. In addition, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk. The impact of this on a newborn isn't yet fully known.
Due to the absence of research, some doctors may be inclined to discontinue stimulant medications during the course of pregnancy. It's a difficult choice for the mother, who must weigh the benefits of taking her medication as well as the potential risks to the fetus. In the meantime, until more information is available, GPs can inquire about pregnant patients if they have any background of ADHD or if they are planning to take medication during the perinatal stage.
Numerous studies have proven that women can continue taking their ADHD medication safely during pregnancy bipolar and adhd medication breast-feeding. In the end, many patients are choosing to do so and, in consultation with their doctor they have found that the benefits of continuing their current medication outweigh any risks.
Women who suffer from ADHD who plan to breastfeed should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should review their medications with their prescriber and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation should also be offered to help women with ADHD understand their symptoms and the underlying disorder Learn about the available treatment options and reinforce existing strategies for managing. This should be a multidisciplinary approach with the GPs, obstetricians and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, monitoring of signs of deterioration and, if needed modifications to the medication regime.